Cargando…

Choice of Outcome Measure Predicts Anti-Inflammatory Treatment Efficacy in Major Depressive Disorder [Letter]

Detalles Bibliográficos
Autores principales:	Wessa, Céline, Morrens, Manuel, De Picker, Livia J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9994662/ https://www.ncbi.nlm.nih.gov/pubmed/36910332 http://dx.doi.org/10.2147/NDT.S407852

Ejemplares similares

Perspective: Solving the Heterogeneity Conundrum of TSPO PET Imaging in Psychosis
por: De Picker, Livia, et al.
Publicado: (2020)

Brain Versus Blood: A Systematic Review on the Concordance Between Peripheral and Central Kynurenine Pathway Measures in Psychiatric Disorders
por: Skorobogatov, Katrien, et al.
Publicado: (2021)

Antipsychotic Treatment Failure: A Systematic Review on Risk Factors and Interventions for Treatment Adherence in Psychosis
por: El Abdellati, Kawtar, et al.
Publicado: (2020)

Tryptophan Catabolites in Bipolar Disorder: A Meta-Analysis
por: Hebbrecht, Kaat, et al.
Publicado: (2021)

Neuroendocrine and Inflammatory Effects of Childhood Trauma Following Psychosocial and Inflammatory Stress in Women with Remitted Major Depressive Disorder
por: Cassiers, Laura L.M., et al.
Publicado: (2019)

Microglia and Brain Plasticity in Acute Psychosis and Schizophrenia Illness Course: A Meta-Review
por: De Picker, Livia J., et al.
Publicado: (2017)

Anti-Inflammatory Treatment Efficacy in Major Depressive Disorder: A Systematic Review of Meta-Analyses
por: Simon, Maria S, et al.
Publicado: (2023)

Comparative Efficacy and Acceptability of Anti-inflammatory Agents on Major Depressive Disorder: A Network Meta-Analysis
por: Hang, Xiaoyi, et al.
Publicado: (2021)

Clinical predictors of kynurenine pathway aberrations in schizophrenia and bipolar disorder
por: Skorobogatov, K., et al.
Publicado: (2022)

Brain Functional Effects of Psychopharmacological Treatment in Major Depression: A Focus on Neural Circuitry of Affective Processing
por: Wessa, Michèle, et al.
Publicado: (2015)

The Interplay of Inflammatory Processes and Cognition in Alcohol Use Disorders—A Systematic Review
por: Coppens, Violette, et al.
Publicado: (2019)

Letter: The Choice of Control Conditions in Animal-Assisted Intervention Research
por: Chubak, Jessica, et al.
Publicado: (2021)

Integrating proteomic and clinical data to discriminate major psychiatric disorders: Applications for major depressive disorder, bipolar disorder, and schizophrenia
por: Shin, Dongyoon, et al.
Publicado: (2022)

Inflammatory Process and Immune System in Major Depressive Disorder
por: Ruiz, Norma Angélica Labra, et al.
Publicado: (2021)

Telomere attrition and inflammatory load in major depressive disorder
por: Squassina, A.
Publicado: (2021)

Hospital-wide SARS-CoV-2 antibody screening of staff in a university psychiatric centre in Belgium
por: El Abdellati, Kawtar, et al.
Publicado: (2021)

Evaluation of inflammatory markers in major psychiatric disorders: challenges and perspectives
por: Wollenhaupt-Aguiar, Bianca
Publicado: (2023)

Value of venous thromboembolism prophylaxis by enoxaparin with anti-factor Xa trough concentration monitoring in surgical care
por: Zachariah, Seeba, et al.
Publicado: (2020)

Diurnal Hypothalamic-Pituitary-Adrenal Axis Measures and Inflammatory Marker Correlates in Major Depressive Disorder
por: Doolin, Kelly, et al.
Publicado: (2017)

Comparative efficacy of escitalopram in the treatment of major depressive disorder
por: Ali, Mazen K, et al.
Publicado: (2011)

The Efficacy of Vortioxetine on Anhedonia in Patients With Major Depressive Disorder
por: Cao, Bing, et al.
Publicado: (2019)

Efficacy of vortioxetine on the physical symptoms of major depressive disorder
por: Christensen, Michael Cronquist, et al.
Publicado: (2018)

Preserved Learning during the Symbol–Digit Substitution Test in Patients with Schizophrenia, Age-Matched Controls, and Elderly
por: Cornelis, Claudia, et al.
Publicado: (2015)

Electroconvulsive therapy plays an irreplaceable role in treatment of major depressive disorder
por: Ma, Mei-Lin, et al.
Publicado: (2022)

Letter to the editor: Triclosan in patients with inflammatory bowel disease
por: Peña-Cardelles, Juan Francisco
Publicado: (2022)

Inflammatory markers in acute ischemic stroke with and without preexisting major depression: Methodological issues
por: Menon, Vikas, et al.
Publicado: (2020)

Comparison of duloxetine and SSRI as a treatment option of painful physical symptoms associated with major depressive disorder
por: Haider, Miqdad, et al.
Publicado: (2017)

Vilazodone in the treatment of major depressive disorder: efficacy across symptoms and severity of depression
por: Khan, Arif, et al.
Publicado: (2014)

Suicidal Risks in Reports of Long-Term Treatment Trials for Major Depressive Disorder
por: Baldessarini, Ross J., et al.
Publicado: (2015)

Major depressive disorder comorbid severe hydrocephalus caused by Arnold–Chiari malformation
por: Kandeger, Ali, et al.
Publicado: (2017)

Deep brain stimulation for the treatment of major depressive disorder: complex psychiatric aspects
por: Waszak, Przemysław M.
Publicado: (2022)

Letter to Editor: Prophylactic Use of Nonsteroidal Anti-Inflammatory Drugs after Cataract Surgery and Corneal Melt
por: Shalchi, Zaid, et al.
Publicado: (2022)

Efficacy of vilazodone on anxiety symptoms in patients with major depressive disorder
por: Thase, Michael E., et al.
Publicado: (2014)

Evaluation of the efficacy and safety of vilazodone for treating major depressive disorder
por: Zhang, Xiao-Fei, et al.
Publicado: (2015)

Comparison of efficacy of ketamine versus thiopentone-assisted modified electroconvulsive therapy in major depression
por: Jagtiani, Amit, et al.
Publicado: (2020)

Reproducibility of the Efficacy of Escitalopram in Patients with Major Depression Who Had Previously Remitted with Escitalopram
por: Yoshimura, Reiji, et al.
Publicado: (2021)

Awareness of Drug–Drug Interaction in Elderly Patients with Osteoarthritis and Depression [Letter]
por: Zhu, Ling-Ling, et al.
Publicado: (2022)

What Should Clinicians Do for Older Adults with Polypharmacy and Depression? [Letter]
por: Zhu, Ling-Ling, et al.
Publicado: (2022)

Stable Schizophrenia Patients Learn Equally Well as Age-Matched Controls and Better than Elderly Controls in Two Sensorimotor Rotary Pursuit Tasks
por: De Picker, Livia J., et al.
Publicado: (2014)

Immune and Neuroendocrine Trait and State Markers in Psychotic Illness: Decreased Kynurenines Marking Psychotic Exacerbations
por: De Picker, Livia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_v6s8cv3cb2in2u5fk52l2kt21j